Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Partin

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
BMC Urology|February 5, 2021
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillanceSamuel W D Merriel, Daniel Moon, Phil Dundee, et al.
Urology|February 22, 2023
IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation StudyJason M Scovell, Mark Stovsky, Alan Partin, et al.
Proteomics. Clinical Applications|December 8, 2010
An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarraysSara Forrester, Ji Qiu, Leslie Mangold, et al.
European Urology|September 22, 2018
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyJames McKiernan, Michael J Donovan, Eric Margolis, et al.
Oncotarget|February 2, 2017
Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patientsMariana Brait, Mithu Banerjee, Leonel Maldonado, et al.
The Journal of Urology|February 28, 2019
Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate CancerMark Stovsky, Eric A Klein, Arnon Chait, et al.
The Canadian Journal of Urology|February 18, 2020
Assessment of high-grade prostate cancer risk using prostate cancer biomarkersWhitney N Stanton, E David Crawford, Paul B Arangua, et al.
JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.
Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.
Theranostics|November 18, 2020
Urinary glycoproteins associated with aggressive prostate cancerMingming Dong, T Mamie Lih, Shao-Yung Chen, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
BMC Urology|February 5, 2021
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillanceSamuel W D Merriel, Daniel Moon, Phil Dundee, et al.
Urology|February 22, 2023
IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation StudyJason M Scovell, Mark Stovsky, Alan Partin, et al.
Proteomics. Clinical Applications|December 8, 2010
An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarraysSara Forrester, Ji Qiu, Leslie Mangold, et al.
European Urology|September 22, 2018
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyJames McKiernan, Michael J Donovan, Eric Margolis, et al.
Oncotarget|February 2, 2017
Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patientsMariana Brait, Mithu Banerjee, Leonel Maldonado, et al.
The Journal of Urology|February 28, 2019
Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate CancerMark Stovsky, Eric A Klein, Arnon Chait, et al.
The Canadian Journal of Urology|February 18, 2020
Assessment of high-grade prostate cancer risk using prostate cancer biomarkersWhitney N Stanton, E David Crawford, Paul B Arangua, et al.
JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.
Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.
Theranostics|November 18, 2020
Urinary glycoproteins associated with aggressive prostate cancerMingming Dong, T Mamie Lih, Shao-Yung Chen, et al.
Pageof 3